![Pieter Oldenziel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Pieter Oldenziel has worked as a Director at Ablynx NV since 2019 and currently holds a position as Managing Director at Sanofi Foreign Participations BV.
Pieter Oldenziel active positions
| Companies | Position | Start |
|---|---|---|
| ABLYNX | Director/Board Member | 31/12/2018 |
Sanofi Foreign Participations BV
 Sanofi Foreign Participations BV Pharmaceuticals: GenericHealth Technology Manufactures human monoclonal antibody drugs | Chief Executive Officer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Develops and produces antibodies | Health Technology |
Sanofi Foreign Participations BV
Sanofi Foreign Participations BV Pharmaceuticals: GenericHealth Technology Manufactures human monoclonal antibody drugs | Health Technology |
- Stock Market
- Insiders
- Pieter Oldenziel
